Vera Therapeutics CEO Marshall Fordyce's 2023 pay slips 16% to $3.4M

Vera Therapeutics reports 2023 executive compensation

By ExecPay News

Published: April 3, 2024

Vera Therapeutics reported fiscal year 2023 executive compensation information on April 3, 2024.
In 2023, three executives at Vera Therapeutics received on average a compensation package of $2.1M, a 24% decrease compared to previous year.
Average pay of disclosed executives at Vera Therapeutics
Marshall Fordyce, Chief Executive Officer, received $3.4M in total, which decreased by 16% compared to 2022. 73% of Fordyce's compensation, or $2.5M, was in option awards. Fordyce also received $32K in bonus, $292K in non-equity incentive plan, as well as $586K in salary.
Sean Grant, Chief Financial Officer, received a compensation package of $1.8M, which decreased by 29% compared to previous year. 64% of the compensation package, or $1.1M, was in option awards.
Celia Lin, Chief Medical Officer, earned $1M in 2023, a 36% decrease compared to previous year.

Related executives

Marshall Fordyce

Vera Therapeutics

Chief Executive Officer

Sean Grant

Vera Therapeutics

Chief Financial Officer

Celia Lin

Vera Therapeutics

Chief Medical Officer

You may also like

Source: SEC filing on April 3, 2024.